Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• (untitled)3 passages
• 78Gy with Fiducial Marker Image-Guided Radiotherapy in Prostate Cancer: Single Center Analysis of 301 Patients.1 passage
• A Rapid Access Clinic to improve delivery of ambulatory care to cancer patients.1 passage
• A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anus.1 passage
• A clinical trial with valproic acid and hydralazine in combination with gemcitabine and cisplatin followed by doxorubicin and dacarbazine for advanced hepatocellular carcinoma.1 passage
• A comparison of clinical staging using the Lugano versus Ann Arbor classifications in Japanese patients with Hodgkin lymphoma.1 passage
• A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.1 passage
• A consensus statement on the use of biosimilar medicines in hematology in Australia.1 passage
• A critical review of abdominopelvic computed tomography for the detection of asymptomatic metastasis in new and recurrent breast cancers.1 passage
• A decade of community-based outcomes of patients treated with curative radiotherapy with or without chemotherapy for non-small cell lung cancer.1 passage
• A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia.1 passage
• A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China.1 passage
• A multicenter, observational study of metastatic breast cancer patients who were treated with eribulin mesylate or taxane-based regimens.1 passage
• A new monitoring tool CLIP test for progression of oxaliplatin-induced peripheral neuropathy: A multicenter prospective study.1 passage
• A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.1 passage
• A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib.1 passage
• A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.1 passage
• A phase II trial of prophylactic olanzapine combined with palonosetron and dexamethasone for preventing nausea and vomiting induced by cisplatin.1 passage
• A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients.1 passage
• A prospective phase II study of raltitrexed combined with S-1 as salvage treatment for patients with refractory metastatic colorectal cancer.1 passage
• A review of whole brain radiotherapy outcomes in a high epidermal growth factor receptor mutation rate population: Does QUARTZ apply in Asia?1 passage
• A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.1 passage
• A simple method of quantifying chemotherapy-induced peripheral neuropathy using PainVision PS-21001 passage
• A study on the association between hyperlipidemia and hypothyroidism and the response to TKIs in metastatic renal cell carcinoma.1 passage
• A systematic review of the barriers to implementing human papillomavirus vaccination programs in low- and middle-income countries in the Asia-Pacific.1 passage
• A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients.1 passage
• ABO blood group and the risk of cancer among middle-aged people in Taiwan.1 passage
• ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.1 passage
• Acute myeloid leukemia with diabetes insipidus and hypophyseal infiltration.1 passage
• Adaptation of international guidelines on assessment and management of cancer pain for the Australian context.1 passage
• Addition of oxaliplatin to neoadjuvant radiochemotherapy in MRI-defined T3, T4 or N+ rectal cancer: a randomized clinical trial.1 passage
• Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasis.1 passage
• Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.1 passage
• Adenoid cystic carcinoma of the lung: Response to tamoxifen after chemoradiation.1 passage
• Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea.1 passage
• Adjuvant therapy after nephrectomy for renal cell carcinoma.1 passage
• Adjuvant therapy for high-risk renal cell carcinoma after nephrectomy how many trials are positive? Only one or more than one.1 passage
• Administrative data provide vital research evidence for maximizing health-system performance and outcomes.1 passage
• Advanced prostate cancer update 2018.1 passage
• Advances and challenges of neoadjuvant therapy in pancreatic cancer.1 passage
• Advances in immune neoadjuvant/adjuvant therapy-related adverse events of non-small cell lung cancer.1 passage
• Afatinib for an EGFR exon 20 insertion mutation: A case report of progressive stage IV metastatic lung adenocarcinoma with 54 months' survival.1 passage
• Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapy.1 passage
• Aflibercept-related nasal septum perforation.1 passage
• Age-based efficacy and safety of nivolumab for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter retrospective study.1 passage
• Allium vegetables are associated with reduced risk of colorectal cancer: A hospital-based matched case-control study in China.1 passage
• An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.1 passage
• An analysis of incidental and symptomatic pulmonary embolism (PE) in medical oncology patients.1 passage
• An e-health strategy to facilitate care of breast cancer survivors: A pilot study.1 passage
• An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.1 passage
• Analysis of colorectal cancer outcomes for the Australian National Bowel Cancer Screening Program.1 passage
• Analysis of neoadjuvant therapies in breast cancer with respect to pathological complete response, disease-free survival and overall survival: 15 years follow-up data from Kuwait.1 passage
• Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers.1 passage
• Anti-angiogenic therapies for gastric cancer.1 passage
• Anti-p16 autoantibodies may be a useful biomarker for early diagnosis of esophageal cancer.1 passage
• Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.1 passage
• Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer.1 passage
• Are cancer survivors well-performing workers? A systematic review.1 passage
• Assessing guideline adherence and patient outcomes in cervical cancer.1 passage
• Association between PD-L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma.1 passage
• Association between deficient levels of circulating vitamin D, dietary intake of vitamin D, calcium and retinol, and risk of colorectal cancer in an Iranian population: A case control study.1 passage
• Association between genetic polymorphisms involved in the hypoxia-inducible factor pathway and lung cancer risk: a case-control study in Japan.1 passage
• Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis.1 passage
• Association of APOBEC3 deletion with cancer risk: A meta-analysis of 26 225 cases and 37 201 controls.1 passage
• Association of genetic variability in enzymes metabolizing chemotherapeutic agents with treatment response in head and neck cancer cases.1 passage
• Association of hormone replacement therapy with increased risk of meningioma in women: A hospital-based multicenter study with propensity score matching.1 passage
• Association of plasma visfatin with risk of colorectal cancer: An observational study of Chinese patients.1 passage
• Attitudes of patients with metastatic cancer towards research biopsies.1 passage
• Australia and New Zealand's responsibilities in improving oncology services in the Asia-Pacific: A call to action.1 passage
• Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer.1 passage
• Autoimmune polyendocrine syndrome type 3, characterized by autoimmune thyroid disease, type 1 diabetes mellitus, and isolated ACTH deficiency, developed during adjuvant nivolumab treatment.1 passage
• Awareness of and preference for disease prognosis and participation in treatment decisions among advanced cancer patients in Myanmar: Results from the APPROACH study.1 passage
• Axillary dissection in sentinel lymph node positive breast cancer: Is the staging information worthwhile for patients?1 passage
• BH3 mimetic ABT-737 induces apoptosis in CD341 passage
• BRCA mutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists.1 passage
• BRCA1 mutation site may be linked with nuclear DNA ploidy in BRCA1-mutated ovarian carcinomas.1 passage
• Barriers and potential solutions to international collaboration in neuro-oncology clinical trials: Challenges from the Australian perspective.1 passage
• Barriers to radiotherapy utilization: Consumer perceptions of issues influencing radiotherapy-related decisions.1 passage
• Benchmarking clinical practice quality: an audit of ipsilateral breast tumor recurrence in patients managed for T1/T2 breast carcinoma.1 passage
• Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study.1 passage
• Bevacizumab-induced transient sixth nerve palsy in ovarian cancer: A case report.1 passage
• Biomarkers and therapeutic advances in glioblastoma multiforme.1 passage
• Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial.1 passage
• Bladder filling volume variation between the first and second day of planning computed tomography for prostate cancer radiation therapy and correlation with renal function.1 passage
• Bone mineral density in women treated for various types of gynecological cancer.1 passage
• Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung.1 passage
• Brain metastasis in sarcoma: Does metastasectomy or aggressive multi-disciplinary treatment improve survival outcomes.1 passage
• Breaking the general practice-hospital divide: Engaging primary care practitioners in multidisciplinary cancer care.1 passage
• Breast cancer quality of care in Taiwan in relation to hospital volume: a population-based cohort study.1 passage
• Breast cancer treatment-related arm lymphoedema and morbidity: A 6-year experience in an Australian tertiary breast centre.1 passage
• CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.1 passage
• CDK4/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care.1 passage
• Cabazitaxel in patients with metastatic castration-resistant prostate cancer: safety and quality of life data from the Australian early access program.1 passage
• Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017.1 passage
• Cancer in Pregnancy.1 passage
• Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change.1 passage
• Cancer outcomes in patients requiring immunosuppression in addition to corticosteroids for immune-related adverse events after immune checkpoint inhibitor therapy.1 passage
• Capecitabine/cisplatin versus 5-fluorouracil/cisplatin in Chinese patients with advanced and metastatic gastric cancer: Re-analysis of efficacy and safety data from the ML17032 phase III clinical trial.1 passage
• Carboplatin and hypomagnesemia: Is it really a problem?1 passage
• Carboplatin plus pemetrexed for the elderly incurable chemo-naive nonsquamous non-small cell lung cancer: Meta-analysis.1 passage
• Cardiovascular immune-related adverse events: Evaluation, diagnosis and management.1 passage
• Case sharing of a patient re-challenged with afatinib for EGFR-mutated advanced non-small cell lung cancer.1 passage
• Causes of death in long-term bladder cancer survivors: A population-based study.1 passage
• Challenging historical perspectives of the 24-h chemotherapy day: Flexible chemotherapy dose-timing guidelines.1 passage
• Changes in DNA methylation after 6-week exercise training in colorectal cancer survivors: A preliminary study.1 passage
• Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea.1 passage
• Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression.1 passage
• Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective.1 passage
• Chemoradiotherapy in elderly patients with advanced head and neck cancer under intensive nutritional support.1 passage
• Chemoradiotherapy versus chemotherapy for locally advanced unresectable pancreatic cancer: A systematic review and meta-analysis.1 passage
• Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival.1 passage
• Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen.1 passage
• Clinical and palliative care outcomes for patients of poor performance status treated with antiprogrammed death-1 monoclonal antibodies for advanced melanoma.1 passage
• Clinical application of a rapid cervical cancer screening method: Folate receptor-mediated staining of cervical neoplastic epithelia.1 passage
• Clinical application of preserving spontaneous breathing non-intubation anesthesia in thoracoscopic surgery for lung cancer under ERAS concept.1 passage
• Clinical benefit and residual kidney function of en bloc nephrectomy for perirenal retroperitoneal sarcoma.1 passage
• Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer.1 passage
• Clinical characteristics of hepatocellular carcinoma patients with normal serum alpha-fetoprotein level: A study of 112 consecutive cases.1 passage
• Clinical characterization of glioblastoma patients living longer than 2 years: A retrospective analysis of two Italian institutions.1 passage
• Clinical concepts for cabazitaxel in the management of metastatic castration-resistant prostate cancer.1 passage
• Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD-1 or PD-L1 inhibitor.1 passage
• Clinical efficacy of concurrent bevacizumab for malignant ascites in nonsquamous cell carcinoma of the lung.1 passage
• Clinical experience with sunitinib dose escalation in metastatic renal cell carcinoma.1 passage
• Clinical factors for predicting malignancy in patients with PSA < 10 ng/mL and PI-RADS 3 lesions.1 passage
• Clinical features and long-term outcomes of aggressive fibromatosis of the abdominal wall after surgical resection: A retrospective study and literature review.1 passage
• Clinical features and long-term outcomes of bilateral Wilms tumor treated with Taiwan Pediatric Oncology Group protocols: A single center report.1 passage
• Clinical features and prognosis of patients with COVID-19 after lung surgery: A retrospective clinical study.1 passage
• Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.1 passage
• Clinical impact of data feedback at lung cancer multidisciplinary team meetings: A mixed methods study.1 passage
• Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy.1 passage
• Clinical outcomes and toxicity of postoperative intensity-modulated versus three-dimensional conformal radiation therapy in patients with cervical cancer.1 passage
• Clinical outcomes of external beam radiotherapy in patients with localized prostate cancer: Does dose escalation matter?1 passage
• Clinical outcomes of whole pelvis radiotherapy and stereotactic body radiotherapy boost for intermediate- and high-risk prostate cancer.1 passage
• Clinical perspectives: practical insights from clinical experience with cabazitaxel in Australia.1 passage
• Clinical response to apatinib monotherapy in advanced non-small cell lung cancer.1 passage
• Clinical results of primary malignant musculoskeletal tumor treated by wide resection and recycling autograft reconstruction using liquid nitrogen.1 passage
• Clinical significance and prognostic value of circulating B10 cells in colorectal cancer.1 passage
• Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.1 passage
• Clinical trials knowledge and attitudes of Vietnamese- and Anglo-Australian cancer patients: A cross-sectional study.1 passage
• Clinical utility of urinary soluble Fas in screening for bladder cancer.1 passage
• Clinicopathologic characteristics and outcome of patients with different EGFR mutations.1 passage
• Clinicopathological features and prognosis of patients with pregnancy-associated breast cancer: A matched case control study.1 passage
• Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.1 passage
• Closing evidence-practice gaps in lung cancer: Results from multi-methods priority setting in the clinical context.1 passage
• Cognitive function in Chinese prostate cancer patients on androgen-deprivation therapy: A cross-sectional study.1 passage
• Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia.1 passage
• Colorectal cancer among Indigenous and non-Indigenous people in Queensland, Australia: Toward survival equality.1 passage
• Colorectal cancer in the United States and a review of its heterogeneity among Asian American subgroups.1 passage
• Combination chemotherapy with NAB1 passage
• Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.1 passage
• Combined association of massive choroidal and optic nerve invasion as a prognostic relevance in primary retinoblastoma: A 10-year study.1 passage
• Combined immune therapy grade IV dermatitis in metastatic melanoma.1 passage
• Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.1 passage
• Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.1 passage
• Comparative effectiveness of nucleos(t)ide analogues in chronic hepatitis B patients undergoing cytotoxic chemotherapy.1 passage
• Comparative performances of the new chronic kidney disease epidemiology equations incorporating cystatin C for use in cancer patients.1 passage
• Comparing single-agent with doublet chemotherapy in first-line treatment of advanced non-small cell lung cancer with performance status 2: a meta-analysis.1 passage
• Comparison between flattening filter-free (FFF) and flattened photon beam VMAT plans for the whole brain radiotherapy (WBRT) with hippocampus sparing.1 passage
• Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial.1 passage
• Comparison between weekly cisplatin-enhanced radiotherapy and cetuximab-enhanced radiotherapy in locally advanced head and neck cancer: first retrospective study in Asian population.1 passage
• Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity.1 passage
• Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study.1 passage
• Comparison of external radiotherapy and percutaneous vertebroplasty for spinal metastasis.1 passage
• Comparison of functional outcomes between laparoscopic radical prostatectomy and robot-assisted laparoscopic radical prostatectomy: a propensity score-matched comparison study.1 passage
• Comparison of gemcitabine plus cisplatin versus capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer.1 passage
• Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.1 passage
• Comparison of safety of loop ileostomy and loop transverse colostomy for low-lying rectal cancer patients undergoing anterior resection: A retrospective, single institution, propensity score-matched study.1 passage
• Comparison of the accuracy of multiparametric magnetic resonance imaging (mpMRI) results with the final pathology findings for radical prostatectomy specimens in the detection of prostate cancer.1 passage
• Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: A randomized double-blinded clinical trial.1 passage
• Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8-day regimen for treatment of low-risk gestational trophoblastic neoplasia.1 passage
• Complementary and alternative medicine use by patients receiving curative-intent chemotherapy.1 passage
• Complete response in a patient with stage IV adrenocortical carcinoma treated with adjuvant trans-catheter arterial chemo-embolization (TACE).1 passage
• Compliance with multidisciplinary team meeting management recommendations.1 passage
• Complications of curative radiation treatment for early prostate cancer.1 passage
• Compression use during an exercise intervention and associated changes in breast cancer-related lymphedema.1 passage
• Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study.1 passage
• Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.1 passage
• Continuous Pringle maneuver does not affect outcomes of patients with hepatocellular carcinoma after curative resection.1 passage
• Conventional supportive cancer care services in Australia: A national service mapping study (The CIA study).1 passage
• Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.1 passage
• Correlation between the protein expression levels of A-kinase anchor protein95, p-retinoblastoma (Ser780), cyclin D2/3, and cyclin E2 in esophageal cancer tissues.1 passage
• Correlations between CD41 passage
• Cost of cancer care for patients undergoing chemotherapy: The Elements of Cancer Care study.1 passage
• Cost-effectiveness of icotinib versus whole-brain irradiation with or without chemotherapy in EGFR-mutant NSCLC patients with brain metastases.1 passage
• Could excision repair cross-complementing group-1 mRNA expression from peripheral blood lymphocytes predict locoregional failure with cisplatin chemoradiation for locally advanced laryngeal cancer?1 passage
• Could yoga practice improve treatment-related side effects and quality of life for women with breast cancer? A systematic review and meta-analysis.1 passage
• Covid-19: What is the best approach in gynecological oncology patient management during the coronavirus pandemic?1 passage
• Cranofacial osteosarcoma: Single institutional experience in Korea.1 passage
• Cultural adaptation and validation of the Chinese version of the expanded prostate cancer index composite.1 passage
• Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers.1 passage
• Current status and future perspectives on immunotherapy in neoadjuvant therapy of resectable non-small cell lung cancer.1 passage
• Current status of PSMA PET imaging in prostate cancer.1 passage
• Current status of total neoadjuvant therapy for locally advanced rectal cancer.1 passage
• Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma.1 passage
• Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution study.1 passage
• Dairy consumption and risk of esophageal squamous cell carcinoma: A meta-analysis of observational studies.1 passage
• Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: National population data over 15 years.1 passage
• Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures.1 passage
• Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.1 passage
• Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.1 passage
• Diagnosis and surgical treatment of mediastinal solitary fibrous tumor.1 passage
• Diagnostic accuracy of MR, CT, and ECT in the differentiation of neoplastic from nonneoplastic spine lesions.1 passage
• Diagnostic accuracy of urine cytokeratin 20 for bladder cancer: A meta-analysis.1 passage
• Diagnostic roles of HOX transcript antisense intergenic RNA in cancer.1 passage
• Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in malignant pleural effusion in patients with lung cancer.1 passage
• Difference in characteristics and outcomes of basaloid squamous cell carcinoma and squamous cell carcinoma, usual type in cervix: A population-based study from SEER 18 database.1 passage
• Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma.1 passage
• Differences in lesion interpretation between radiologists in two countries: Lessons from a digital breast tomosynthesis training test set.1 passage
• Differences in ultrasonographic features between males and females with breast cancer of the luminal A and luminal B molecular subtypes.1 passage
• Different aberrant expression pattern of immune checkpoint receptors in patients with PTCL and NK/T-CL.1 passage
• Different genetic alteration of A20 in a Sézary syndrome case with Vα2-Jα22 T cell clone.1 passage
• Different patterns of treatment-related adverse events of programmed cell death-1 and its ligand-1 inhibitors in different cancer types: A meta-analysis and systemic review of clinical trials.1 passage
• Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey.1 passage
• Discrimination of ascitic fluid infection in malignant ascites by polymorphonuclear neutrophil ratio and count: Investigating the validity of count ≥250/mm1 passage
• Dismal outcome of relapsed or primary refractory adult T-cell lymphoblastic lymphoma: A retrospective study from China.1 passage
• Distribution of tumor subtypes in bilateral breast cancer: Comparison between synchronous and metachronous cancer.1 passage
• Disulfiram-copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cells.1 passage
• Do FHIT gene alterations play a role in human solid tumors?1 passage
• Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.1 passage
• Do histopathological features of breast cancer in Australian Indigenous women explain the survival disparity? A two decade long study in the Northern Territory.1 passage
• Do patients discussed at a lung cancer multidisciplinary team meeting receive guideline-recommended treatment?1 passage
• Docetaxel and cisplatin induction chemotherapy with or without fluorouracil in locoregionally advanced nasopharyngeal carcinoma: A retrospective propensity score matching analysis.1 passage
• Docetaxel-based adjuvant therapy for breast cancer patients in Asia-Pacific region: Results from 5 years follow-up on Asia-Pacific Breast Initiative-I.1 passage
• Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?1 passage
• Does primary tumor volume predict the outcome of pediatric nasopharyngeal carcinoma?: A prospective single-arm study using neoadjuvant chemotherapy and concomitant chemotherapy with intensity modulated radiotherapy.1 passage
• Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials.1 passage
• Dosimetric comparison of volumetric-arc therapy versus sliding window intensity-modulated radiotherapy in postoperative treatment for primary soft tissue sarcoma of the thigh.1 passage
• Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.1 passage
• Downregulation of nicotinamide nucleotide transhydrogenase and its naturally occurring antisense RNA in gastric cancer.1 passage
• Drug induced vitiligo-like depigmentation from a CDK 4/6 inhibitor.1 passage
• Drug-eluting bead transarterial chemoembolization with medium-sized versus small-sized CalliSpheres microspheres in unresectable primary liver cancer.1 passage
• Duodenal gastrointestinal stromal tumors: A retrospective study based on a 13 years experience of a single center in China.1 passage
• Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumab.1 passage
• Early radiation-induced liver toxicities are associated with poor survival in patients with advanced hepatocellular carcinoma.1 passage
• Early recognition of ipilimumab-related autoimmune hypophysitis in patients with metastatic melanoma: Case studies and recommendations for management.1 passage
• Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate.1 passage
• Edmondson grade predicts survival of patients with primary clear cell carcinoma of liver after curative resection: A retrospective study with long-term follow-up.1 passage
• Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.1 passage
• Effect of diabetes mellitus comorbidity on outcomes in stages II and III colorectal cancer.1 passage
• Effect of neurological monitoring in postoperative 5-15 days residual thyroidectomy after primary thyroid cancer surgery.1 passage
• Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.1 passage
• Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer.1 passage
• Effect of the allelic variants of ABCB1, CYP2D6 and HTR3B on response of ramosetron to prevent chemotherapy-induced nausea and vomiting in Korean cancer patients.1 passage
• Effect of the underlying malignancy on critically ill septic patient's outcome.1 passage
• Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.1 passage
• Effectiveness of image-guided radiotherapy for rectal cancer patients treated with neoadjuvant concurrent chemoradiotherapy: A population-based propensity score-matched analysis.1 passage
• Effectiveness of neoadjuvant concurrent chemoradiotherapy versus up-front proctectomy in clinical stage II-III rectal cancer: A population-based study.1 passage
• Effectiveness of stereotactic body radiotherapy for portal vein tumor thrombosis in patients with hepatocellular carcinoma and underlying chronic liver disease.1 passage
• Efficacy and safety of amrubicin-based regimen used as first-line for extensive-disease small-cell lung cancer: A meta-analysis of randomized controlled trials.1 passage
• Efficacy and safety of bio-chemotherapy with dacarbazine plus interleukin-2 in patients with unresectable malignant melanoma.1 passage
• Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.1 passage
• Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study.1 passage
• Efficacy and safety of chronomodulated chemotherapy for patients with metastatic colorectal cancer: a systematic review and meta-analysis.1 passage
• Efficacy and safety of late-course hypofractionated radiation therapy for muscle-invasive bladder carcinoma after bladder-conserving surgery.1 passage
• Efficacy and safety of oxycodone/naloxone as add-on therapy to gabapentin or pregabalin for the management of chemotherapy-induced peripheral neuropathy in Korea.1 passage
• Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.1 passage
• Efficacy and safety of sunitinib alternate day regimen in patients with metastatic renal cell carcinoma in Japan: Comparison with standard 4/2 schedule.1 passage
• Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era.1 passage
• Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case-control study.1 passage
• Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: A real-world data analysis.1 passage
• Efficacy of benzydamine oral rinse in prevention and management of radiation-induced oral mucositis: A double-blind placebo-controlled randomized clinical trial.1 passage
• Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration-resistant prostate cancer: A local experience of a multicenter retrospective study.1 passage
• Efficacy of endoscopy in assessing the local disease response in nasopharyngeal carcinoma patients after treated with intensity-modulated radiotherapy.1 passage
• Efficacy of icotinib in lung squamous-cell cancer: A real-world experience from single institution.1 passage
• Efficacy of late line pertuzumab with trastuzumab and chemotherapy in HER2-positive metastatic breast cancer: An Australian case series.1 passage
• Efficacy of management strategies for aromatase inhibitor-induced arthralgia in breast cancer patients: a systematic review.1 passage
• Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer.1 passage
• Efficacy of trastuzumab emtansine in Japanese patients with previously treated HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma: A subgroup analysis of the GATSBY study.1 passage
• Efficacy, safety and pharmacokinetics of subcutaneous azacitidine in Chinese patients with higher risk myelodysplastic syndromes: Results from a multicenter, single-arm, open-label phase 2 study.1 passage
• Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC.1 passage
• Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes.1 passage
• Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment.1 passage
• Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.1 passage
• Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer.1 passage
• Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer.1 passage
• End of life experiences of patients with advanced cancer in Myanmar: Results from the APPROACH study.1 passage
• End-of-life care of oncology inpatients: Are we getting it right?1 passage
• End-of-life care: Where do cancer patients want to die? A systematic review.1 passage
• Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non-small cell lung cancer cells.1 passage
• Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.1 passage
• Epidemiology of breast cancer in Indian women.1 passage
• Epidemiology of head and neck cancer in Thailand.1 passage
• Epigenetic regulation in gallbladder cancer: Promoter methylation profiling as emergent novel biomarkers.1 passage
• Epigenetic silencing of ZBTB28 promotes renal cell carcinogenesis.1 passage
• Estimating radiotherapy demands in South East Asia countries in 2025 and 2035 using evidence-based optimal radiotherapy fractions.1 passage
• Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: an evidence-based benchmark for cancer care.1 passage
• Estimation of malignancy of pulmonary nodules at CT scans: Effect of computer-aided diagnosis on diagnostic performance of radiologists.1 passage
• Estimation of the prevalence and direct medical costs of chronic myeloid leukemia in the I.R. of Iran in the era of tyrosine kinase inhibitors.1 passage
• Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging.1 passage
• Evaluating the predictive factors for anastomotic leakage after total laparoscopic resection with transrectal natural orifice specimen extraction for colorectal cancer.1 passage
• Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation.1 passage
• Evaluation of low-dose thalidomide as induction and maintenance therapy in patients with multiple myeloma not eligible for stem cell transplantation.1 passage
• Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma.1 passage
• Evaluation of the use of fluoroscopy guided needle biopsies for diagnosing cases of suspected pathological fractures.1 passage
• Examining clinicians' perceptions of head and neck cancer (HNC) information.1 passage
• Exercise recommendations and referral patterns of oncology professionals.1 passage
• Exercise therapy in oncology rehabilitation in Australia: A mixed-methods study.1 passage
• Exosomal miR-21/Let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases.1 passage
• Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers.1 passage
• Experiences of barriers and facilitators to establishing and sustaining radiotherapy services in low- and middle-income countries: A qualitative study.1 passage
• Experiences of interpreters in supporting the transition from oncology to palliative care: A qualitative study.1 passage
• Exploring treatment decision-making in cancer management for rural residents: Patient and provider perspectives on a recently established regional radiotherapy service.1 passage
• Expression of CD73 is associated with tumor progression and intratumoral inflammation in breast cancer.1 passage
• Expression of VEGF-D in epithelial ovarian cancer and its relationship to lymphatic metastasis.1 passage
• Expression of WW domain-containing oxidoreductase and its clinical implication in endometrial adenocarcinoma patients with metabolic syndrome.1 passage
• External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program.1 passage
• External-beam radiation therapy versus surgery in the treatment of hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombi.1 passage
• FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center.1 passage
• FLT3-ITD positive acute myeloid leukemia: A retrospective analysis of the role of allogeneic transplant and allelic ratio in patient management.1 passage
• Factors associated with fear of cancer recurrence in breast and colorectal cancer survivors: A cross-sectional study of cancer survivors.1 passage
• Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.1 passage
• Failure patterns and prognostic factors for cervical node-negative nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.1 passage
• Favorable 10-year outcomes of image-guided intensity-modulated radiotherapy combined with long-term androgen deprivation for Japanese patients with nonmetastatic prostate cancer.1 passage
• Feasibility and kinetics of CD341 passage
• Female sex, good performance status, and bevacizumab-induced hypertension associated with survival benefit in Asian patients with recurrent glioblastoma treated with bevacizumab.1 passage
• Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.1 passage
• First reported case of interferon-alpha-induced sarcoidosis in an Asian patient with malignant melanoma.1 passage
• First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment.1 passage
• First-line therapy for metastatic colorectal cancer: Current perspectives and future directions.1 passage
• Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer.1 passage
• Frontline treatment of epithelial ovarian cancer.1 passage
• Gastrointestinal stromal tumors in kidney transplant recipients: Report of two cases and literature review.1 passage
• Gastrostomy dependency trends over 15 years of patients at a large tertiary referral center following the insertion of a prophylactic gastrostomy for chemoradiation for mucosal head and neck cancer.1 passage
• Gender- and cholesterol-specific predictive value of body mass index in renal cell carcinoma: A multicenter study.1 passage
• Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.1 passage
• Genetic aberrations involved in relapse of pediatric acute myeloid leukemia: A literature review.1 passage
• Genome-wide expression profiling and bioinformatics analysis of deregulated genes in human gastric cancer tissue after gastroscopy.1 passage
• HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.1 passage
• Hand-foot skin reaction predicts treatment outcome of pazopanib in patients with metastatic soft tissue sarcoma: A multicenter study in the Asian population.1 passage
• Head and neck adaptive radiotherapy: Predicting the time to replan.1 passage
• Health state utilities in non-small cell lung cancer: An international study.1 passage
• Heart failure following blood cancer therapy in pediatric and adult populations.1 passage
• Hematological toxicities associated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.1 passage
• Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.1 passage
• High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.1 passage
• High-dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15-year multicenter experience.1 passage
• Higher frequency of the CTLA-41 passage
• Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape.1 passage
• Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.1 passage
• Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm.1 passage
• Hospitalizations in solid tumor phase I clinical trial patients: Incidence, pattern and clinical outcomes at an Australian phase I clinical trial unit.1 passage
• How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?1 passage
• Hsa-miR-27a-3p and epidermal growth factor receptor expression analysis in glioblastoma FFPE samples.1 passage
• Human epidermal growth factor receptor 2 status of breast cancer patients in Asia: Results from a large, multicountry study.1 passage
• Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study.1 passage
• Hurdles in radiation planning for glioblastoma: Can delayed-contrast enhanced computed tomography be a potential solution?1 passage
• Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest study.1 passage
• Hypofractionated radiation treatment in early breast cancer: Results in a New Zealand setting.1 passage
• Ibrutinib-related atrial fibrillation: A single center Australian experience.1 passage
• Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival.1 passage
• Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review.1 passage
• Identifying ultrasound features of positive expression of Ki67 and P53 in breast cancer using radiomics.1 passage
• Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.1 passage
• Image-guided percutaneous microwave ablation of early-stage non-small cell lung cancer.1 passage
• Immune checkpoint inhibitor therapy for cancer patients infected with HIV: A systematic review.1 passage
• Immune checkpoint inhibitor use in antisynthetase syndrome.1 passage
• Immune checkpoint inhibitor-associated myositis and myasthenia gravis overlap: Understanding the diversity in a case series.1 passage
• Immune checkpoint inhibitor-related cutaneous adverse events.1 passage
• Immune checkpoint inhibitors: Navigating a new paradigm of treatment toxicities.1 passage
• Immunomodulation characteristics by thermal ablation therapy in cancer patients.1 passage
• Immunotherapy for urothelial carcinoma: Metastatic disease and beyond.1 passage
• Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer.1 passage
• Impact of COVID-19 on cancer patients: A review.1 passage
• Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum.1 passage
• Impact of a brief exercise program on the physical and psychosocial health of prostate cancer survivors: A pilot study.1 passage
• Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic.1 passage
• Impact of body mass index on the oncological outcomes of patients with upper and lower urinary tract cancers treated with radical surgery: A multi-institutional retrospective study.1 passage
• Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.1 passage
• Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center.1 passage
• Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups.1 passage
• Impact of modified FOLFOX-6 for patients with gastric cancer and a gastrointestinal obstruction.1 passage
• Impact of sequential lines of palliative chemotherapy in patients with recurrent/metastatic esophageal squamous cell carcinoma: A retrospective analysis of 107 patients at a single center.1 passage
• Impact of the early detection of esophageal neoplasms in hypopharyngeal cancer patients treated with concurrent chemoradiotherapy.1 passage
• Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer.1 passage
• Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendations.1 passage
• Inadequate treatment practices for pain relief and adverse event management in cancer patients across 10 countries/regions in Asia: a call for greater efforts to improve standards for patient care.1 passage
• Incidence and mortality rates of lung cancer in Qingdao, China (2013-2017).1 passage
• Incidence of esophageal cancer in Sri Lanka: Analysis of cancer registry data and comparison with other South Asian populations.1 passage
• Incidence of oral cancer in Western Australia (1982-2009): Trends and regional variations.1 passage
• Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region.1 passage
• Incidence, survival and stage at diagnosis of small intestinal neuroendocrine tumours in Queensland, Australia, 2001-2015.1 passage
• Incidental gallbladder cancer after laparoscopic cholecystectomy: incidence, management, and prognosis.1 passage
• Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia.1 passage
• Increased TOX expression concurrent with PD-1, Tim-3, and CD244 in T cells from patients with non-Hodgkin lymphoma.1 passage
• Increased exhausted CD81 passage
• Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation.1 passage
• Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemia.1 passage
• Indigenous Australians with non-small cell lung cancer or cervical cancer receive suboptimal treatment.1 passage
• Inflammatory breast cancer: A decade of experience.1 passage
• Infliximab for ipilimumab-induced colitis: A series of 13 patients.1 passage
• Influence of socioeconomic factors and distance to radiotherapy on breast-conserving surgery rates for early breast cancer in regional Australia; implications of change.1 passage
• Initial experience of sleeve lobectomy under complete video-assisted thoracic surgery.1 passage
• Integration of complementary and alternative medicine into cancer-specific supportive care programs in Australia: A scoping study.1 passage
• Intensity modulated radiation therapy after extra-pleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival.1 passage
• Interleukin-18 (IL-18) is equally expressed in inflammatory breast cancer and noninflammatory locally advanced breast cancer: A possible association with chemotherapy response.1 passage
• Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.1 passage
• International survey of awareness of genetic risk in the clinical sarcoma community.1 passage
• Interpolation to define clinical tumor stage in prostate cancer using clinical description of digital rectal examination.1 passage
• Interpretative characteristics and case features associated with the performances of radiologists in reading mammograms: A study from a non-screening population in Asia.1 passage
• Intravenous versus oral dexamethasone for prophylaxis of paclitaxel-associated hypersensitivity reaction in patients with primary ovarian, fallopian tube and peritoneal cancer: A double-blind randomized controlled trial.1 passage
• Intrinsic resistance to sunitinib in patients with metastatic renal cell carcinoma.1 passage
• Investigation of estimated glomerular filtration rate and its perioperative change in patients with upper urinary tract urothelial carcinoma: A multi-institutional retrospective study.1 passage
• Is concomitant splenectomy necessary in radical gastric cancer surgery? A systematic review and meta-analysis.1 passage
• Is definitive concurrent chemoradiotherapy effective for locally advanced head and neck cancer in the elderly aged ≥ 75 years: A single-institute, retrospective, cohort study.1 passage
• Is hepatectomy an appropriate option for bilobar liver metastasis with portal vein tumor thrombus of colorectal cancer?1 passage
• Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?1 passage
• Is the Memorial Sloan Kettering Cancer Centre (MSKCC) sarcoma nomogram useful in an Asian population?1 passage
• Keeping primary care "in the loop": General practitioners want better communication with specialists and hospitals when caring for people diagnosed with cancer.1 passage
• Knudson's hypothesis revisited in Indian retinoblastoma patients.1 passage
• LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.1 passage
• La protein contributes to cells proliferation and migration and serves as a potential therapeutic target for hepatocellular carcinoma.1 passage
• Leptomeningeal enhancement on preoperative brain MRI in patients with glioblastoma and its clinical impact.1 passage
• Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wall.1 passage
• Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife1 passage
• Long-term effect of exemestane therapy on bone mineral density supported by bisphosphonates: Results of 5-year adjuvant treatment in postmenopausal women with early-stage breast cancer.1 passage
• Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia.1 passage
• Long-term outcomes for patients with acute myeloid leukemia: a single-center experience from AIIMS, India.1 passage
• Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study.1 passage
• Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study.1 passage
• Long-term survival and prognostic analysis of advanced stage follicular lymphoma in the rituximab era: A China single-center retrospective study.1 passage
• Longitudinal study of intravenous versus subcutaneous immunoglobulin replacement therapy in hematological malignancy.1 passage
• Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx).1 passage
• Loss of CDX-2 expression is an independent poor prognostic biomarker in patients with early-stage deficient mismatch repair colorectal cancer.1 passage
• Loss of adipose tissue or skeletal muscle during first-line gemcitabine/nab-paclitaxel therapy is associated with worse survival after second-line therapy of advanced pancreatic cancer.1 passage
• Low-frequency ultrasound combined with microbubbles improves gene transfection in prostate cancer cells in vitro and in vivo.1 passage
• Lower trial participation by culturally and linguistically diverse (CALD) cancer patients is largely due to language barriers.1 passage
• Lower tumor volume is associated with increased benefit from immune checkpoint inhibitors in patients with advanced non-small-cell lung cancer.1 passage
• Lung cancer presenting as thin-walled cysts: An analysis of 15 cases and review of literature.1 passage
• Lung cancer treatment patterns and factors relating to systemic therapy use in Australia.1 passage
• Lymph nodes metastasis in cervical cancer: Incidences, risk factors, consequences and imaging evaluations.1 passage
• MAML1 and TWIST1 co-overexpression promote invasion of head and neck squamous cell carcinoma.1 passage
• MR-guided simulation is superior than FDG/PET-guided simulation for local control in nasopharyngeal cancer patients treated with intensity-modulated radiotherapy.1 passage
• Mainstream consent programs for genetic counseling in cancer patients: A systematic review.1 passage
• Male Breast Cancer in Australia.1 passage
• Mammographic interpretation in Vietnam: Tailored educational strategies are needed to increase clinicians' expertise.1 passage
• Mammography performance in Oman: Review of factors influencing cancer yield and positive predictive value.1 passage
• Management of advanced prostate cancer in Hong Kong: Insights from an APCCC-Derived survey.1 passage
• Management of epidermal growth factor receptor tyrosine kinase inhibitor-related cutaneous and gastrointestinal toxicities.1 passage
• Management of indeterminate pulmonary nodules (<1 cm) newly detected during the follow-up of nasopharyngeal carcinoma patients.1 passage
• Management of lateral pelvic lymph nodes by Australasian colorectal surgeons: An insight from the west.1 passage
• Management of patients treated with pertuzumab in the Australian clinical practice setting.1 passage
• Management of patients with follicular lymphoma treated first line with obinutuzumab.1 passage
• Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review.1 passage
• Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.1 passage
• Mechanisms of long non-coding RNA function in colorectal cancer tumorigenesis.1 passage
• Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14-16 August 2019, National Canberra Convention Centre, Canberra, Australia.1 passage
• Medical and non-medical expenditure for breast cancer diagnosis and treatment in China: a multicenter cross-sectional study.1 passage
• Metabolic behavior and prognostic role of pretreatment 18F-FDG PET/CT in gist.1 passage
• Metabolic profiling analysis for clinical urine of colorectal cancer.1 passage
• Metastatic gastric cancer: Does the site of metastasis make a difference?1 passage
• Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies.1 passage
• Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.1 passage
• MicroRNA profiles in neuroblastoma: Differences in risk and histology groups.1 passage
• Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients.1 passage
• Models of childhood cancer survivorship care in Australia and New Zealand: Strengths and challenges.1 passage
• Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors).1 passage
• Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).1 passage
• Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.1 passage
• N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.1 passage
• NKX2-5, SIL/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T-cell acute lymphoblastic leukemia.1 passage
• National and provincial population-based incidence and mortality of skin cancer in Iran; 1990-2016.1 passage
• Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.1 passage
• Neoadjuvant intra-arterial chemotherapy in advanced laryngeal and hypopharyngeal cancer.1 passage
• Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.1 passage
• Neurological immune-related adverse events associated with immune checkpoint inhibitors: A review of the literature.1 passage
• Neutrophil count kinetics during the first cycle of chemotherapy predicts the outcome of patients with locally advanced or metastatic pancreatic cancer.1 passage
• Nimotuzumab, a humanized monoclonal antibody specific for the EGFR, in combination with temozolomide and radiation therapy for newly diagnosed glioblastoma multiforme: First results in Chinese patients.1 passage
• Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.1 passage
• Nucleophosmin mutation in de-novo acute myeloid leukemia.1 passage
• Number of negative lymph nodes as a prognostic factor in esophageal squamous cell carcinoma.1 passage
• Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.1 passage
• Olaparib dose re-escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series.1 passage
• Oncologist provision of smoking cessation support: A national survey of Australian medical and radiation oncologists.1 passage
• Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature.1 passage
• Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials.1 passage
• Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer.1 passage
• Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists.1 passage
• Optimizing skeletal-related events prevention in patients with advanced prostate cancer.1 passage
• Oral cyclophosphamide in recurrent ovarian cancer.1 passage
• Oral mucositis among Chinese cancer patients receiving chemotherapy: Effects and management strategies.1 passage
• Osimertinib 160 mg daily for advanced non-small cell lung cancer with leptomeningeal metastasis: A case report.1 passage
• Outcome of cervix uteri cancer patients: Clinical treatment results and toxicity profile in a retrospective study from Saudi Arabia.1 passage
• Outcome of chemotherapy with or without targeted agents in metastatic colorectal cancer patients with deficient DNA mismatch repair: A single center, cohort study.1 passage
• Outcomes of Asian patients with localized prostate cancer treated with combined intensity modulated radiation therapy (IMRT) and high dose rate (HDR) brachytherapy: A single institution experience.1 passage
• Outcomes of Australian patients receiving non-funded anti-PD-1 immune checkpoint inhibitors for non-melanoma cancers.1 passage
• Outcomes of universal germline testing for men with prostate cancer in an Australian tertiary center.1 passage
• Outcomes of women at high familial risk for breast cancer: An 8-year single-center experience.1 passage
• Ovarian cancer study dropouts had worse health-related quality of life and psychosocial symptoms at baseline and over time.1 passage
• Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.1 passage
• Overexpression of LINC00852 promotes prostate cancer cell proliferation and metastasis.1 passage
• Oxaliplatin/5-fluorouracil-based adjuvant chemotherapy as a standard of care for colon cancer in clinical practice: Outcomes of the ACCElox registry.1 passage
• Oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe, chronic cancer pain: Challenges in the context of hepatic impairment.1 passage
• PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma.1 passage
• PD-L1 heterogeneity in patients with non-small cell lung cancer.1 passage
• Palliative 5-fluorouracil and cisplatin chemotherapy in recurrent metastatic sebaceous carcinoma: Case report and literature review.1 passage
• Partial chest wall radiation therapy for positive or close surgical margins after modified radical mastectomy for breast cancer without lymph node metastasis.1 passage
• Pathological and therapeutic aspects of matrix metalloproteinases: Implications in osteosarcoma.1 passage
• Pathological outcomes in rectal cancer following laparoscopic surgery.1 passage
• Pathological outcomes of HER2-positive non-metastatic breast cancer patients treated with neoadjuvant dual anti-HER2 therapy and taxane: An Australian experience.1 passage
• Pathological risk factors in upper urinary tract cancer.1 passage
• Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population.1 passage
• Patient outcomes of whole brain radiotherapy for brain metastases versus leptomeningeal metastases: A retrospective study.1 passage
• Patient preferences on the integration of complementary therapy with conventional cancer care.1 passage
• Patient reported experience of the burden of neuroendocrine tumors and impact of eSHINE Patient Support Program on patient quality of life.1 passage
• Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey.1 passage
• Patient-reported quality of life, unmet needs and care coordination outcomes: Moving toward targeted breast cancer survivorship care planning.1 passage
• Patients' experiences and preferences for opt-in models and health professional involvement in biobanking consent: A cross-sectional survey of Australian cancer outpatients.1 passage
• Pattern of care and survival of anaplastic lymphoma kinase rearranged non-small cell lung cancer (ALK+ NSCLC) in an Australian Metropolitan Tertiary Referral Centre: A retrospective cohort analysis.1 passage
• Patterns of care and outcomes of men with germ cell tumors in a high-volume Australian center.1 passage
• Patterns of care for orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in Korea throughout 2016: Results from a multicenter cross-sectional cohort study (KROG 16-19).1 passage
• Patterns of care for stage III non-small cell lung cancer in Australia.1 passage
• Patterns of care of superficial soft tissue sarcomas: it is not always just a lump.1 passage
• Patterns of follow-up care after curative radiotherapy ± chemotherapy for stage I-III non-small cell lung cancer.1 passage
• Patterns of health services utilization in the last two weeks of life among cancer patients: Experience in an Australian academic cancer center.1 passage
• Patterns of oxycodone controlled release use in older people with cancer following public subsidy of oxycodone/naloxone formulations: An Australian population-based study.1 passage
• Patterns of surveillance for colorectal cancer: Experience from a single large tertiary institution.1 passage
• Percutaneous endobiliary radiofrequency ablation and stents in management of hepatocellular carcinoma with bile duct tumor thrombus: Initial single-institution experience.1 passage
• Performance status as prognostic factor in phase III trials of first-line chemotherapy of unresectable or metastatic pancreatic cancer: A trial-level meta-analysis.1 passage
• Perioperative versus postoperative chemotherapy for gastric cancer: A propensity score matched analysis.1 passage
• Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes.1 passage
• Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study).1 passage
• Phase II APEC trial: The impact of primary tumor side on outcomes of first-line cetuximab plus FOLFOX or FOLFIRI in patients with RAS wild-type metastatic colorectal cancer.1 passage
• Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer.1 passage
• Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients.1 passage
• Phase II study on hepatic arterial infusion chemotherapy using percutaneous catheter placement techniques for liver metastases from colorectal cancer (JFMC28 study).1 passage
• Phase III randomized trial comparing intravenous to oral iron in patients with cancer-related iron deficiency anemia not on erythropoiesis stimulating agents.1 passage
• Physalin B inhibits cell proliferation and induces apoptosis in undifferentiated human gastric cancer HGC-27 cells.1 passage
• Pineal calcification is associated with pediatric primary brain tumor.1 passage
• Planning magnetic resonance imaging for prostate cancer intensity-modulated radiation therapy: Impact on target volumes, radiotherapy dose and androgen deprivation administration.1 passage
• Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer.1 passage
• Posterior reversible encephalopathy syndrome mimicking brain metastases in a patient with metastatic transitional cell carcinoma.1 passage
• Postoperative radiotherapy improves overall survival in patients with primary squamous cell carcinoma of the breast.1 passage
• Potential issues with complementary medicines commonly used in the cancer population: A retrospective review of a tertiary cancer center's experience.1 passage
• Potential molecular signatures in epithelial ovarian cancer by genome wide expression profiling.1 passage
• Poultry and fish intake and risk of esophageal cancer: A meta-analysis of observational studies.1 passage
• Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib.1 passage
• Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer.1 passage
• Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer.1 passage
• Precision oncology using a clinician-directed, tailored approach to molecular profiling.1 passage
• Predictors in breast cancer screening behaviors of South Asian women.1 passage
• Predictors of care for patients with cancer of unknown primary site in three Australian hospitals.1 passage
• Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone-naïve prostate cancer: The first real-life experience in Asia.1 passage
• Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.1 passage
• Presence of pleural effusion is associated with a poor prognosis in patients with epidermal growth factor receptor-mutated lung cancer receiving tyrosine kinase inhibitors as first-line treatment.1 passage
• Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.1 passage
• Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection.1 passage
• Prevalence of autoimmune hemolytic anemia in multiple myeloma: A prospective study.1 passage
• Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.1 passage
• Prevention of docetaxel-associated febrile neutropenia with primary granulocyte colony-stimulating factor in Chinese metastatic hormone-sensitive and castration-resistant prostate cancer patients.1 passage
• Preventive effect of daikenchuto, a traditional Japanese herbal medicine, on onset of ileus after gynecological surgery for malignant tumors.1 passage
• Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs).1 passage
• Primary tumor location is an important predictive factor for wild-type KRAS metastatic colon cancer treated with cetuximab as front-line bio-therapy.1 passage
• Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.1 passage
• Prime time for immunotherapy in advanced urothelial cancer.1 passage
• Prior or concurrent radiotherapy and nivolumab immunotherapy in non-small cell lung cancer.1 passage
• Probiotics reduce psychological stress in patients before laryngeal cancer surgery.1 passage
• Production and characterization of haploidentical CD19 CAR T cells: Validated to induce a continuous complete remission in a patient with relapsed refractory B-cell ALL.1 passage
• Prognoses in patients with primary gastrointestinal neuroendocrine neoplasms based on the proposed new classification scheme.1 passage
• Prognostic analysis for children with hepatoblastoma with lung metastasis: A single-center analysis of 98 cases.1 passage
• Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.1 passage
• Prognostic factors and survival rate of osteosarcoma: A single-institution study.1 passage
• Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization.1 passage
• Prognostic performance of qSOFA in oncology patients admitted to the emergency department with suspected infection.1 passage
• Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer.1 passage
• Prognostic significance of KIT exon 11 deletion mutation in intermediate-risk gastrointestinal stromal tumor.1 passage
• Prognostic significance of interim1 passage
• Prognostic value of 18F-FDG PET parameters in patients with locally advanced non-small cell lung cancer treated with induction chemotherapy.1 passage
• Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.1 passage
• Prognostic value of cyclooxygenase-2 gene polymorphisms in advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.1 passage
• Prognostic value of enhancement rate by enhanced ultrasound in hepatitis B virus-positive hepatocellular carcinoma undergoing radiofrequency ablation.1 passage
• Programmed cell death 1 (PD-1)/PD-ligand 1(PD-L1) inhibitors-related pneumonitis in patients with advanced non-small cell lung cancer.1 passage
• Programmed death ligand-1 expression levels, clinicopathologic features, and survival in surgically resected sarcomatoid lung carcinoma.1 passage
• Prophylactic cranial irradiation in small cell lung cancer: A single institution experience.1 passage
• Prophylaxis of neutropenic fever with ciprofloxacin in patients with acute myeloid leukemia treated with intensive chemotherapy.1 passage
• Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.1 passage
• Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer.1 passage
• Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer.1 passage
• Psoas muscle depletion during preoperative chemotherapy for advanced gastric cancer has a negative impact on long-term outcomes after gastrectomy.1 passage
• Psychological distress among prostate cancer survivors in South Korea: A nationwide population-based, longitudinal study.1 passage
• Psychosocial concerns of cancer patients in Singapore.1 passage
• Psychosocial effects of appearance changes due to cancer treatment and needs for information and supportive care in Japanese cancer patients.1 passage
• Quality and impact of eviQ Cancer Treatments Online (www.eviq.org.au): the medical oncologist's perspective.1 passage
• Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.1 passage
• R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.1 passage
• RPRD1B is a potentially molecular target for diagnosis and prevention of human papillomavirus E6/E7 infection-induced cervical cancer: A case-control study.1 passage
• Radiation oncology during COVID-19: Strategies to avoid compromised care.1 passage
• Radiation recall pneumonitis induced by erlotinib after palliative thoracic radiotherapy for lung cancer: Case report and literature review.1 passage
• Radiation-associated breast cancers in a late-effects cohort: Long-term surveillance is essential.1 passage
• Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: Results of a large retrospective study.1 passage
• Radiotherapy for brainstem gliomas in children and adults: A single-institution experience and literature review.1 passage
• Radiotherapy for metastatic spinal cord compression; can the Rades score predict survival?1 passage
• Radiotherapy for prostate cancer: Effect of gold fiducial markers on diffusion-weighted magnetic resonance imaging.1 passage
• Radiotherapy service need in the Pacific Island countries.1 passage
• Radiotherapy utilization in BRAF mutation-tested metastatic melanoma in the targeted therapy era.1 passage
• Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study.1 passage
• Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial.1 passage
• Re-evaluation of the prognostic significance of retropharyngeal node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.1 passage
• Re-inventing the randomized controlled trial in medical oncology: The registry-based trial.1 passage
• Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer.1 passage
• Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.1 passage
• Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma.1 passage
• Real-world experience of the feasibility and tolerability of the 2/1 dosing schedule with sunitinib in the treatment of patients with advanced renal cell carcinoma in Australia.1 passage
• Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer.1 passage
• Real-world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed-dose combination to prevent chemotherapy-induced nausea and vomiting among Malaysian patients receiving moderately or highly emetogenic chemotherapy.1 passage
• Real-world outcome with abiraterone acetate plus prednisone in Asian men with metastatic castrate-resistant prostate cancer: The Singapore experience.1 passage
• Real-world treatment patterns and outcomes in refractory metastatic colorectal cancer.1 passage
• Receipt of radiotherapy after mastectomy in women with breast cancer: Population-based cohort study in New Zealand.1 passage
• Recognition and management of the gastrointestinal and hepatic immune-related adverse events.1 passage
• Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in Singapore.1 passage
• Recommended testing algorithms for NTRK gene fusions in pediatric and selected adult cancers: Consensus of a Singapore Task Force.1 passage
• Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service.1 passage
• Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry.1 passage
• Regression of a metastatic lung mass after receiving whole brain irradiation: Can the abscopal effect cross the blood-brain barrier?1 passage
• Relationship between progression-free survival and overall survival in patients with advanced non-small cell lung cancer treated with anticancer agents after first-line treatment failure.1 passage
• Relative value of ultrasound, computed tomography and positron emission tomography imaging in the clinically node-negative neck in oral cancer.1 passage
• Reliability and validity of the Cancer Health Literacy Test - Chinese versions: CHLT-30-Chinese and CHLT-6-Chinese.1 passage
• Renal immune-related adverse events of immune checkpoint inhibitor.1 passage
• Resection arthrodesis and osteoarticular allografts reconstruction after resection of primary bone tumors around the knee: Long-term clinical outcomes and prognostic factors for failure of biological reconstruction.1 passage
• Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia.1 passage
• Resveratrol induced apoptosis in human gastric carcinoma SGC-7901 cells via activation of mitochondrial pathway.1 passage
• Retrospective analysis of hospital admissions due to immune checkpoint inhibitor-induced immune-related adverse events (irAE).1 passage
• Retrospective analysis of treatment and prognosis for uterine leiomyosarcoma: 10-year experience of a single institute.1 passage
• Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.1 passage
• Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.1 passage
• Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis.1 passage
• Revisiting the role of bone-modifying agents in the management of metastatic prostate cancer.1 passage
• Rheumatic immune-related adverse events induced by immune checkpoint inhibitors.1 passage
• Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival.1 passage
• Risk factors for locoregional relapse after radical nephrectomy.1 passage
• Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim.1 passage
• Risk of febrile neutropenia and early treatment cessation in men receiving standard and dose-reduced 3-weekly docetaxel for metastatic castration-resistant prostate cancer.1 passage
• Risk of nasopharyngeal carcinoma in patients with chronic rhinosinusitis: A nationwide propensity score matched study in Taiwan.1 passage
• Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.1 passage
• Robotic radiosurgery of head and neck paragangliomas: a single institution experience.1 passage
• Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance.1 passage
• Role of adjuvant chemotherapy in T2N0M0 periampullary cancers.1 passage
• Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors.1 passage
• S-1 plus cisplatin as first-line treatment of patients with advanced non-small cell lung cancer in Taiwan.1 passage
• Safety and accuracy of core biopsy in retroperitoneal sarcomas.1 passage
• Safety and efficacy of aflibercept in combination with fluorouracil, leucovorin and irinotecan in the treatment of Asian patients with metastatic colorectal cancer.1 passage
• Safety and efficacy of sunitinib for advanced non-clear cell renal cell carcinoma.1 passage
• Salivary interleukin-6 in the detection of oral cancer and precancer.1 passage
• Salvage stereotactic body radiotherapy for locally recurrent uterine cervix cancer at the pelvic sidewall: Feasibility and complication.1 passage
• Satisfaction with pain management and impact of pain on quality of life in cancer patients.1 passage
• Screening and surveillance for gastric cancer: Does family history play an important role in shaping our strategy?1 passage
• Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).1 passage
• Serum level of interleukin-35 as a potential prognostic factor for gastric cancer.1 passage
• Serum protein profiles of patients with lung cancer of different histological types.1 passage
• Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.1 passage
• Short-term multimodal prehabilitation improves functional capacity for colorectal cancer patients prior to surgery.1 passage
• Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.1 passage
• Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.1 passage
• Significance of baseline computed tomography assessment for predicting the pulmonary fibrosis during the course of chemotherapy-induced pneumonitis.1 passage
• Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.1 passage
• Simultaneous optimization of limited sampling points for pharmacokinetic analysis of amrubicin and amrubicinol in cancer patients.1 passage
• Single institution retrospective review of perioperative chemotherapy in adult and adolescent patients with operable osteosarcoma.1 passage
• Single institutional series of neuroendocrine tumors managed in the Australian Capital Territory.1 passage
• Single-center analysis of antiresorptive agent-related osteonecrosis of the jaw in lung cancer patients.1 passage
• Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks.1 passage
• Solitary pituitary metastasis from HER2-positive breast cancer.1 passage
• Soluble CD44 and CD44v6 and prognosis in children with B-cell acute lymphoblastic leukemia.1 passage
• Spectrum of EGFR gene mutations in Vietnamese patients with non-small cell lung cancer.1 passage
• Spindle cell metaplastic carcinoma of breast: A clinicopathological and immunohistochemical analysis.1 passage
• Staging research of human lung cancer tissues by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy (HRMAS1 passage
• Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer.1 passage
• Stereotactic body radiotherapy prolongs the progression-free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer.1 passage
• Stimulating immune responses to fight cancer: Basic biology and mechanisms.1 passage
• Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial.1 passage
• Strong opioid prescription in cancer patients in their final year of life: A population-based analysis using a Taiwanese health insurance database.1 passage
• Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer.1 passage
• Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.1 passage
• Suitability of endobronchial ultrasound-guided transbronchial needle aspiration samples for programmed death ligand-1 testing in non-small cell lung cancer, the Bristol experience.1 passage
• Superparamagnetic iron oxide nanoparticles for MR imaging of pancreatic cancer: Potential for early diagnosis through targeted strategies.1 passage
• Surgery for the palliation of intestinal perforation from secondary metastases in advanced malignancies.1 passage
• Surgical approach selection for total spondylectomy for the treatment of giant cell tumors in the lumbar spine: A retrospective analysis of 12 patients from a single center.1 passage
• Surgical treatment and outcome of early invasive adenocarcinoma of the uterine cervix (FIGO stage IA1).1 passage
• Survival analysis for older patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after progression of first-line gefitinib.1 passage
• Survival and cardiac toxicity in patients with HER2-positive, metastatic breast cancer treated with trastuzumab in routine clinical practice.1 passage
• Survival and medical costs of melanoma patients with subsequent cancer diagnoses: A South Korean population-based retrospective cohort study.1 passage
• Survival of lung cancer patients in a resource-limited country.1 passage
• Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level.1 passage
• Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.1 passage
• Sustained response to standard dose osimertinib in a patient with plasma T790M-positive leptomeningeal metastases from primary lung adenocarcinoma.1 passage
• Switching between endocrine therapies for primary breast cancer: Frequency and timing in Australian clinical practice.1 passage
• Synergistic antitumor activity of pro-apoptotic agent PAC-1 with cisplatinum by the activation of CASP3 in pulmonary adenocarcinoma cell line H1299.1 passage
• Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.1 passage
• Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review.1 passage
• TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype.1 passage
• TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment.1 passage
• Tamoxifen use in recurrent ovarian cancer in a Chinese population: A 15 -year clinical experience in a tertiary referral center.1 passage
• Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysis.1 passage
• Terminal differentiation of bone marrow NK cells and increased circulation of TIGIT1 passage
• The IHC4+C score: an affordable and reproducible non-molecular decision-aid in hormone receptor-positive breast cancer. Does it still hold value for patients in 2020?1 passage
• The INTERNET STUDY: A phase II study of everolimus in patients with fluorodeoxyglucose (1 passage
• The Living Well after Breast Cancer™ Pilot Trial: a weight loss intervention for women following treatment for breast cancer.1 passage
• The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: A meta-analysis.1 passage
• The VAC regimen for adult rhabdomyosarcoma: Differences between adolescent/young adult and older patients.1 passage
• The adverse events associated with combination immunotherapy in cancers: Challenges and chances.1 passage
• The analysis of surgical prognostic factors and molecular typing of locally advanced lung squamous cell carcinomas.1 passage
• The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.1 passage
• The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation.1 passage
• The challenge of putting principles into practice: Resource tensions and real-world constraints in multidisciplinary oncology team meetings.1 passage
• The changing paradigm of management in melanoma brain metastases.1 passage
• The changing paradigm of managing Merkel cell carcinoma in Australia: An expert commentary.1 passage
• The characteristics of oncology social work in Australia: Implications for workforce planning in integrated cancer care.1 passage
• The current practice, preparedness and educational preparation of oncology professionals to provide spiritual care.1 passage
• The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma.1 passage
• The diameter of metastasis in positive sentinel lymph node biopsy affects axillary tumor load in early breast cancer.1 passage
• The effects of switching EGFR-TKI treatments for non-small cell lung cancer because of adverse events.1 passage
• The efficacy and safety of everolimus for the treatment of progressive gastroenteropancreatic neuroendocrine tumors: A multi-institution observational study in Taiwan.1 passage
• The efficacy of axitinib as a first-line treatment for metastatic renal cell carcinoma.1 passage
• The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.1 passage
• The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable.1 passage
• The impact of bevacizumab in metastatic colorectal cancer with an intact primary tumor: Results from a large prospective cohort study.1 passage
• The impact of type 2 diabetes mellitus on mortality in hospitalized female cancer patients in Taiwan.1 passage
• The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ-Ⅲ colorectal cancer.1 passage
• The incidence and patterns of gastric cancers in Sri Lanka from 2001 to 2012: Analysis of National Cancer Registry Data.1 passage
• The management of HER2-positive early breast cancer: Current and future therapies.1 passage
• The mechanism of propofol in cancer development: An updated review.1 passage
• The minimum standard of care for managing malignant pleural mesothelioma in developing nations within the Asia-Pacific Region.1 passage
• The national trend of the gastric cancer burden in Iran from 1990 to 2017.1 passage
• The outcomes of adrenalectomy for solitary adrenal metastasis: A 17-year single-center experience.1 passage
• The patient co-payment and opportunity costs of accessing healthcare for Indigenous Australians with cancer: A whole of population data linkage study.1 passage
• The prevalence and predictors of subsyndromal anxiety and depression in adult Asian cancer patients across the first year of diagnosis.1 passage
• The prognosis of patients with lung cancer admitted to the medical intensive care unit.1 passage
• The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.1 passage
• The prognostic value of aspartate aminotransferase-to-lymphocyte ratio index in early-stage hepatocellular carcinoma after hepatectomy: A propensity-score matched analysis.1 passage
• The prognostic value of fluorodeoxyglucose positron emission tomography metabolic tumor volume in solitary colorectal liver metastasis.1 passage
• The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer.1 passage
• The rapidly escalating cost of treating colorectal cancer in Australia.1 passage
• The rationale and toxicity of combined cranial radiotherapy and immune checkpoint inhibitors in non-small cell lung cancer.1 passage
• The role of bile acid subtypes in the diagnosis of cholangiocarcinoma.1 passage
• The role of combining immunotherapy with primary (Chemo)radiotherapy in curative treatment settings of the head and neck cancer.1 passage
• The role of immunosuppressive agents in the management of severe and refractory immune-related adverse events.1 passage
• The role of postoperative radiotherapy after primary tumor resection in patients with de novo stage IV breast cancer.1 passage
• The significance of Delphian lymph node in papillary thyroid cancer.1 passage
• The survival benefit of radiotherapy in localized primary adult rhabdomyosarcoma.1 passage
• The use of trastuzumab in New Zealand women with breast cancer.1 passage
• The value of blood biomarkers of progression and prognosis in ALK-positive patients with non-small cell lung cancer treated with crizotinib.1 passage
• The value of magnetic resonance imaging in esophageal carcinoma: Tool or toy?1 passage
• The venous thromboembolism prophylaxis in patients receiving thoracic surgery: A systematic review.1 passage
• Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first-line induction therapy for newly diagnosed multiple myeloma in a single institution of China.1 passage
• Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study.1 passage
• Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma.1 passage
• Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.1 passage
• Tissue factor pathway inhibitor 2 suppresses the growth of thyroid cancer cells through by induction of apoptosis.1 passage
• To biopsy or not to biopsy? Outcomes following stereotactic body radiotherapy (SBRT) for biopsy-confirmed versus radiologically-diagnosed primary lung cancer in a single Australian institution.1 passage
• Total thyroidectomy is superior for initial treatment of thyroid cancer.1 passage
• Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.1 passage
• Tracheo-bronchial adenoid cystic carcinoma: A retrospective study.1 passage
• Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?1 passage
• Translation and psychometric testing of Cancer Survivors' Unmet Needs, Chinese version.1 passage
• Treatment and outcomes of melanoma in Asia: Results from the National Cancer Centre Singapore.1 passage
• Treatment and outcomes of unresectable and metastatic pancreatic cancer treated in public and private Australian hospitals.1 passage
• Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis.1 passage
• Treatment interruption during radiation therapy: Experience at a single institution in the Republic of Korea.1 passage
• Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.1 passage
• Treatment of elderly patients with acute myeloid leukemia with azacitidine results in fewer hospitalization days and infective complications but similar survival compared with intensive chemotherapy.1 passage
• Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease.1 passage
• Treatment outcomes of patients with involved resection margin after rectal cancer surgery: A nationwide population-based cohort study in South Korea.1 passage
• Treatment patterns in patients with advanced gastric cancer in Taiwan.1 passage
• Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options.1 passage
• Treatment-related toxicities of immune checkpoint inhibitors in advanced cancers: A meta-analysis.1 passage
• Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real-world multi-institution cohort study.1 passage
• Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia.1 passage
• Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.1 passage
• Tumor volume and sphericity as predictors of local control after stereotactic radiosurgery for limited number (1-4) brain metastases from nonsmall cell lung cancer.1 passage
• UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis.1 passage
• USP21 upregulation in cholangiocarcinoma promotes cell proliferation and migration in a deubiquitinase-dependent manner.1 passage
• Updates to the drug-resistant mechanism of proteasome inhibitors in multiple myeloma.1 passage
• Upregulation of O-GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia.1 passage
• Uptake of clinical trials in a palliative care setting: a retrospective cohort study.1 passage
• Using a Delphi process to determine optimal care for patients with pancreatic cancer.1 passage
• Using primary tumor volumetry to predict treatment outcome for patients with oropharyngeal cancer who were treated with definitive chemoradiotherapy.1 passage
• Uterine adenosarcoma in Japan: Clinicopathologic features, diagnosis and management.1 passage
• Utilization of stereotactic ablative radiotherapy in oligometastatic & oligoprogressive skeletal metastases: Results and pattern of failure.1 passage
• Utilization pattern and survival outcomes of adjuvant therapies in high-grade nonretroperitoneal abdominal soft tissue sarcoma: A population-based study.1 passage
• Validating a proxy for disease progression in metastatic cancer patients using prescribing and dispensing data.1 passage
• Validation of the emotion thermometers and hospital anxiety and depression scales in Singapore: Screening cancer patients for distress, anxiety and depression.1 passage
• Validity and reliability of the MD Anderson dysphagia inventory in English and Chinese in head and neck cancer patients.1 passage
• Value of 3Tesla MRI in the preoperative staging of mid-low rectal cancer and its impact on clinical strategies.1 passage
• Very high-risk prostate cancer: stratification by outcomes of radiotherapy and long-term androgen deprivation therapy.1 passage
• Viable versus nonviable positive margins in Ewing sarcoma and associated recurrence rates: A systematic review.1 passage
• Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series.1 passage
• Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.1 passage
• What contributes to resilience in cancer patients? A principal component analysis of the Connor-Davidson Resilience Scale.1 passage
• What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?1 passage
• What is the value of third-line chemotherapy in advanced gastroesophageal cancer? A 5-year retrospective analysis at a single center.1 passage
• When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival.1 passage
• Which factors are associated with extremely short-term survival after surgery in patients with esophageal squamous cell carcinoma?1 passage
• Who are the optimal candidates for partial breast irradiation?1 passage
• Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians.1 passage
• Young breast cancer and the influence of ethnicity in Sandakan: A 3-year retrospective cross-sectional study.1 passage
• Young-onset colorectal cancer is associated with a personal history of type 2 diabetes.1 passage
• miR-425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression.1 passage
• nab-Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial.1 passage
• v-myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B-cell acute lymphoblastic leukemia.1 passage